
BIOCERES CROP SOLUTIONS CORP
BIOXNASDAQπ #4126 by market capUS Equity
$0.37β² $0.01 (+3.00%)
Live1hβ² 0.6%
24hβ² 3.0%
7dβΌ 0.6%
14dβ² 16.0%
30dβ² 9.0%
1yβΌ 88.3%
π¦Market Cap
$24M
Small Cap
πRevenue Growth (YoY)
-44.7%
Declining
πGross Margin
37.6%
Healthy
π΅FCF Margin
28.4%
Strong
βοΈP/S Ratio
0.1x
Cheap
Otter Score
50
Weak
Trading Snapshot
- Day Range
- $0.37 β $0.38
- 52-Week Range
- $0.30 β $3.33
- Volume
- $2.57B
- Avg Volume
- $3.38B
- Shares Outstanding
- 63.8M
- Next Earnings
- Sep 6, 2026
Fundamentals Snapshot
- Annual Revenue
- $265M
- Last Q Revenue
- $64M
- P/E Ratio
- β
- P/S Ratio
- 0.1x
- EPS (TTM)
- $-3.88
- Dividend Yield
- β
Why Investors Own BIOX
- βHigh-growth profile β revenue up +47.3% YoY with expanding US Equity exposure.
- βHealthy economics β 39% gross margin and 22% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
β οΈ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$265Mβ² +54.3% YoY
Gross Margin (TTM)
39.0%β² +1.0% YoY
Operating Income (TTM)
$50Mβ² +54.3% YoY
Free Cash Flow (TTM)
$58Mβ² +54.3% YoY
About BIOCERES CROP SOLUTIONS CORP
A company profile for BIOCERES CROP SOLUTIONS CORP isnβt available yet β check back soon.
π¦¦
Otter Score Breakdown
βπQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
β‘Momentumβ
β
β
β
β
Overall Score
Weak
50/100
Analyst Price Target
βAverage Target
$0.44
β² +17.6% Upside
High Target$0.51
Low Target$0.34
Based on 20 analysts
Latest News & Updates
π
ReutersΒ·2h ago
BIOCERES CROP SOLUTIONS CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
π°οΈ
MarketWatchΒ·5h ago
Analysts lift BIOX price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
π
MarketWatchΒ·1d ago
BIOCERES CROP SOLUTIONS CORP announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.